Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling is an effective and safe way to prevent hair loss from chemotherapy, with manageable side effects and low risk of scalp cancer.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Some breast cancer chemotherapy can cause permanent hair loss.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Scalp cooling is an effective way to prevent hair loss from chemotherapy.

Cannabis, cryotherapy, and scalp cooling can help improve the quality of life for chemotherapy patients.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Scalp cooling prevented hair loss in half of the patients, despite significant side effects.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

PLD is an effective and safer alternative for treating breast cancer.

Annurca apple extract may protect mouse hair from damage by chemotherapy and could help treat hair loss without promoting cancer growth.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Scalp cooling effectively reduces hair loss from chemotherapy.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.